+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gene Therapy"

Cell Analysis - Global Strategic Business Report - Product Thumbnail Image

Cell Analysis - Global Strategic Business Report

  • Report
  • February 2026
  • 273 Pages
  • Global
From
CRISPR Technology - Global Strategic Business Report - Product Thumbnail Image

CRISPR Technology - Global Strategic Business Report

  • Report
  • February 2026
  • 220 Pages
  • Global
From
From
Synthetic Genes - Global Strategic Business Report - Product Thumbnail Image

Synthetic Genes - Global Strategic Business Report

  • Report
  • February 2026
  • 181 Pages
  • Global
From
Synthetic DNA - Global Strategic Business Report - Product Thumbnail Image

Synthetic DNA - Global Strategic Business Report

  • Report
  • February 2026
  • 181 Pages
  • Global
From
Gene Delivery Systems - Global Strategic Business Report - Product Thumbnail Image

Gene Delivery Systems - Global Strategic Business Report

  • Report
  • February 2026
  • 196 Pages
  • Global
From
Cancer Gene Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Gene Therapy - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Viral Vector Manufacturing - Global Strategic Business Report - Product Thumbnail Image

Viral Vector Manufacturing - Global Strategic Business Report

  • Report
  • February 2026
  • 402 Pages
  • Global
From
Transfection Technologies - Global Strategic Business Report - Product Thumbnail Image

Transfection Technologies - Global Strategic Business Report

  • Report
  • February 2026
  • 192 Pages
  • Global
From
Oligonucleotide Synthesis - Global Strategic Business Report - Product Thumbnail Image

Oligonucleotide Synthesis - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Expression Vectors - Global Strategic Business Report - Product Thumbnail Image

Expression Vectors - Global Strategic Business Report

  • Report
  • February 2026
  • 196 Pages
  • Global
From
Genomics - Global Strategic Business Report - Product Thumbnail Image

Genomics - Global Strategic Business Report

  • Report
  • February 2026
  • 292 Pages
  • Global
From
RNA Interference (RNAi) - Global Strategic Business Report - Product Thumbnail Image

RNA Interference (RNAi) - Global Strategic Business Report

  • Report
  • February 2026
  • 178 Pages
  • Global
From
From
RNA Interference- Pipeline Insight, 2025 - Product Thumbnail Image

RNA Interference- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 204 Pages
  • Global
From
Inflammation And Pain Post Cataract Surgery - Pipeline Insight, 2025 - Product Thumbnail Image

Inflammation And Pain Post Cataract Surgery - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Wiskott-Aldrich Syndrome Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Wiskott-Aldrich Syndrome Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
Loading Indicator

Gene therapy is a form of genomics that involves the introduction of genetic material into a patient's cells to treat or prevent a disease. It is a rapidly growing field of medicine, with the potential to revolutionize the treatment of genetic diseases. Gene therapy works by introducing a healthy gene into a patient's cells, replacing a defective gene or providing a missing gene. This can be done through a variety of methods, such as viral vectors, gene editing, and stem cell therapy. Gene therapy has the potential to provide long-term, curative treatments for a wide range of genetic diseases, including cancer, cystic fibrosis, and hemophilia. It is also being explored as a potential treatment for other conditions, such as Alzheimer's disease and Parkinson's disease. Gene therapy is a rapidly growing field, with many companies investing in research and development. Companies in the gene therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Spark Therapeutics. Show Less Read more